Portevo
US Companies
AMGNNasdaq

Amgen Financial Results (AMGN)

Report publication dates, analyst consensus, and how Amgen's share price reacted to previous earnings — all in one place, in English.

Updated: October 11, 2026

Share Price
414.87 USD
+1.82%
Market Cap
$224.29 bn
Next Report
November 3, 2026
confirmed date
Earnings Beat
100%
out of 4 last quarters
Average Share Price Movement
6.07%
on the session after publication
P/E Ratio
25.77
Amgen's Performance vs. ForecastsThe company beat analyst forecasts in 100% of the last 4 quarters.100%above forecasts
Percentage of quarters where Amgen's earnings beat analyst consensus — out of 4 recent reports.

When Amgen Reports Earnings

The next Amgen report is scheduled for November 3, 2026. The date is based on the company's announcement.

The expected earnings per share (EPS) is 5.76 USD. Analyst forecasts range from 5.47 to 6.13 USD. The market reacts not to the absolute earnings, but to the difference between the actual result and this forecast.

Expected revenue: 10.05 B USD.

Amgen's Latest Earnings Report: What the Numbers Showed

Amgen's latest earnings report covers the quarter ended June 30, 2026. Revenue was $10.05 billion, and net income was $2.38 billion. Earnings per share (EPS) reached $6.29 compared to analysts' forecasts of $5.62 — 11.97% above expectations. On the first trading day after the release, the share price changed by +7.64%.

Revenue
$10.05 bn
for the quarter
Net income
$2.38 bn
for the quarter
EPS
6.29 USD
forecast 5.62
Surprise
+11.97%
vs. consensus
Share price after report
+7.64%
next trading day
Net margin
23.62%
net income to revenue

Insider Transactions: Amgen

Who from the management board, supervisory board, US Congress, or government bought and sold shares of this company — based on official filings.

Insider Buys · 12 mo.
25
≈ $285K
Sales · 12 mo.
25
Unique individuals
13
in the last year
Last transaction
September 22, 2026
Latest transactionsForm 4, STOCK Act, OGE, MAR
Dave Taylor
Dave Taylor · Sell AMGN
$1k–$15kAugust 26, 2026
Dave Taylor
Dave Taylor · Sell AMGN
$1k–$15kAugust 26, 2026
Rachna Khosla · Sell AMGN
$521K13 August 2026
Sheldon Whitehouse
Sheldon Whitehouse · Sell AMGN
Amgen · Spouse
$1k–$15kAugust 12, 2026
Rachna Khosla · Sell AMGN
$825K11 August 2026
Derek Miller · Sell AMGN
$1.6M August 6, 2026
Nancy A. Grygiel · Sell AMGN
$1.2M August 6, 2026
See insider faces on the chart in the app →

How the stock reacted to past earnings

The company beat analyst estimates in 100% of the last 4 quarters.

The average share price change on the day after earnings release is 6.07% — regardless of direction. The largest move was 7.95%. This number says more about the risk of holding a position through an earnings report than the earnings forecast itself.

Amgen Share Price Reaction to EarningsBar chart: Amgen share price change on the day after the last 4 earnings releases. The price increased after 3 of them and decreased after 1. The largest movement was 7.95%.+7.95%Nov 25+6.24%Feb 26-2.43%Q26+7.64%Aug 26
Amgen share price change on the day of the report's release. Green bars indicate an increase, red bars a decrease.
EPS Forecast vs. Actual — AmgenBar chart comparing EPS forecasts with Amgen's actual results over the last 4 quarters. Results were higher than forecasts in 4 of them.5.015.64Q3 254.735.29Q4 254.775.15Q1 265.626.29Q2 26analyst forecastCompany earnings
Amgen's earnings per share: analyst forecast and actual result, in USD.
Amgen's quarterly results — forecast, actual performance, and share price behavior on the day of release. EPS values in USD.
QuarterRelease dateEPS estimateActual EPSSurpriseShare price reaction
June 30, 2026August 4, 20265.626.29+11.97%+7.64%
March 31, 2026April 30, 20264.775.15+8.04%-2.43%
December 31, 2025February 3, 20264.735.29+11.94%+6.24%
September 30, 2025November 4, 20255.015.64+12.47%+7.95%

How much this company's stock moves after earnings

Amgen's share price changes by an average of 6.07% on the first trading day after earnings releases — based on the last 4 reports, regardless of direction. This ranks 81 out of 180 companies for which we calculated this statistic.

Analyst forecasts for upcoming periods

The consensus is the average of many analysts' forecasts. The more analysts behind a number, the less likely it is to be a single error—but forecast agreement is never a guarantee of the actual result.

Forecasts for Amgen — EPS values in USD.
PeriodEPS estimateEPS a year agoChangeRevenue forecastAnalysts
Current quarter5.765.64+2.21%$10.05 bn27
Next quarter5.815.29+9.74%$10.27 bn27
Current year23.0421.84+5.47%$38.95 bn33
Next year24.4823.04+6.29%$40.36 bn33

Revenue and margins quarter by quarter

Margin shows how much of sales a company retains. Rising revenue with shrinking margins means growth is coming at the expense of profitability—and that's usually more interesting than sales growth alone.

Amgen Revenue and MarginBar chart of Amgen's quarterly revenue over the last 5 quarters; revenue is growing, with the overlaid line showing net margin.Q2 25Q3 25Q4 25Q1 26Q2 2615.60%33.65%13.51%21.11%23.62%Quarterly revenueNet margin
Amgen's quarterly revenue in USD and net margin for the same quarter.
Amgen's quarterly income statement.
QuarterRevenueGross marginOperating marginNet margin
June 30, 2026$10.05 bn72.04%34.95%23.62%
March 31, 2026$8.62 bn68.16%30.94%21.11%
December 31, 2025$9.87 bn69.84%27.57%13.51%
September 30, 2025$9.56 bn67.75%26.43%33.65%
June 30, 2025$9.18 bn67.20%28.94%15.60%

Amgen Dividend

The last ex-dividend date was August 21, 2026. The date of the next payment is not yet known — it depends on the resolution of the general meeting, and Yahoo only publishes the date after it has been announced.

Dividend Yield
2.47%
from the last payment
Per Share
10.08 USD
annually
Payout Ratio
60.87%
portion of profit returned to shareholders
Ex-dividend date
August 21, 2026
last known

Who Reports in the Coming Weeks

Dates from the Portevo calendar — companies in the same industry are listed first, as their earnings often move the share prices of their peers even before their own reports.

About Amgen

Amgen Inc. is listed on Nasdaq under the ticker AMGN, and its headquarters are in the United States. The company is in the healthcare sector (industry: Drug Manufacturers - General).

  • Ticker: AMGN
  • Exchange: Nasdaq
  • Trading Currency: USD
  • Sector: healthcare
  • Number of Analysts Providing Estimates: 29
  • 52-Week Range: 288.00 – 447.03
  • Company website: https://www.amgen.com

Frequently Asked Questions

When does Amgen report earnings?

The next report is due on November 3, 2026.

What were Amgen's earnings last quarter?

For the quarter ended June 30, 2026: revenue 10.05 billion USD, net income 2.38 billion USD, EPS 6.29 USD. This was +11.97% above analyst forecasts.

What is Amgen's ticker symbol?

AMGN — on Nasdaq. You may also see AMGN on quote services.

What is the earnings per share forecast for Amgen?

The analyst consensus for the upcoming quarter is $5.76 per share. Individual forecasts range from $5.47 to $6.13.

How much does Amgen's share price usually change after earnings?

On average, 6.07% in the session after publication, counting both directions. The largest recorded movement was 7.95%.

Does Amgen usually beat analyst forecasts?

In the last 4 quarters, results exceeded forecasts in 100% of cases. History does not predict the next report, but it shows how cautiously analysts approach this company.

Where can I check Amgen's financial results in English?

On Portevo — the earnings calendar, analyst forecasts, surprise history, and share price reactions are available for free and without an account.

Other companies in the healthcare sector

A company's earnings are most informative when compared to competitors in the same industry — this shows whether a weak quarter was a company-specific issue or a market-wide trend.

Related

Track Amgen on Portevo

The company page in the app includes a price chart, indicators, and industry comparisons. Add a company to your watchlist, and its report will be highlighted in the earnings calendar—along with the rest of your portfolio.

Portevo is not an investment advisor. The data and analyses are for informational and educational purposes only and do not constitute a recommendation or an offer to buy or sell financial instruments. Quotes are from external providers and may be delayed. You make investment decisions at your own risk.

Portevo App

Your entire portfolio, company earnings, and insider trades in one place

Upload your XTB report or add companies manually — Portevo will calculate your net profit after costs, show you the earnings dates for your companies, and display insider faces on charts.

  • Portfolio with Net Profit After Costs
  • Earnings Calendar for Your Companies
  • Pelosi, Trump, and CEO Trades on a Chart
  • Works in Browser and on iPhone

No credit card required. A demo portfolio is available immediately; create your own by uploading a report.

Portevo Portfolio: Value, Net Performance, and ChartCompany Earnings Calendar in the Portevo AppETF Fact Sheet with Quotes in PortevoTransaction History and Portfolio Tracking in Portevo
Portevo — free portfolio, earnings, and insider tradesOpen App